No Data
No Data
Stifel Maintains Third Harmonic Bio(THRD.US) With Buy Rating, Maintains Target Price $23
Third Harmonic Bio, Inc. (THRD) Receives a Buy From Stifel Nicolaus
We're Not Very Worried About Third Harmonic Bio's (NASDAQ:THRD) Cash Burn Rate
Morgan Stanley Maintains Third Harmonic Bio(THRD.US) With Buy Rating, Maintains Target Price $20
Analysts Are Bullish on Top Healthcare Stocks: Third Harmonic Bio, Inc. (THRD), Collegium Pharmaceutical (COLL)
Third Harmonic Bio to Participate in Upcoming Investor Conferences in November